Literature DB >> 19301420

Concentration and drug prices in the retail market for malaria treatment in rural Tanzania.

Catherine Goodman1, S Patrick Kachur, Salim Abdulla, Peter Bloland, Anne Mills.   

Abstract

The impact of market concentration has been little studied in markets for ambulatory care in the developing world, where the retail sector often accounts for a high proportion of treatments. This study begins to address this gap through an analysis of the consumer market for malaria treatment in rural areas of three districts in Tanzania. We developed methods for investigating market definition, sales volumes and concentration, and used these to explore the relationship between antimalarial retail prices and competition.The market was strongly geographically segmented and highly concentrated in terms of antimalarial sales. Antimalarial prices were positively associated with market concentration. High antimalarial prices were likely to be an important factor in the low proportion of care-seekers obtaining appropriate treatment.Retail sector distribution of subsidised antimalarials has been proposed to increase the coverage of effective treatment, but this analysis indicates that local market power may prevent such subsidies from being passed on to rural customers. Policymakers should consider the potential to maintain lower retail prices by decreasing concentration among antimalarial providers and recommending retail price levels. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301420      PMCID: PMC2689512          DOI: 10.1002/hec.1473

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  28 in total

Review 1.  Viewpoint: management of malaria--working with the private sector.

Authors:  R Brugha; D Chandramohan; A Zwi
Journal:  Trop Med Int Health       Date:  1999-05       Impact factor: 2.622

2.  Averting a malaria disaster.

Authors:  N J White; F Nosten; S Looareesuwan; W M Watkins; K Marsh; R W Snow; G Kokwaro; J Ouma; T T Hien; M E Molyneux; T E Taylor; C I Newbold; T K Ruebush; M Danis; B M Greenwood; R M Anderson; P Olliaro
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

3.  Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria?

Authors:  U D'Alessandro; A Talisuna; M Boelaert
Journal:  Trop Med Int Health       Date:  2005-01       Impact factor: 2.622

4.  Competition in the NHS internal market: an overview of its effects on hospital prices and costs.

Authors:  C Propper; N Söderlund
Journal:  Health Econ       Date:  1998-05       Impact factor: 3.046

5.  Tuberculosis patients and practitioners in private clinics in India.

Authors:  M Uplekar; S Juvekar; S Morankar; S Rangan; P Nunn
Journal:  Int J Tuberc Lung Dis       Date:  1998-04       Impact factor: 2.373

6.  Managing markets.

Authors:  J A Roberts
Journal:  J Public Health Med       Date:  1993-12

7.  Hospitals and antitrust: defining markets, setting standards.

Authors:  J Zwanziger; G Melnick; K M Eyre
Journal:  J Health Polit Policy Law       Date:  1994       Impact factor: 2.265

8.  Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?

Authors:  Catherine Goodman; S Patrick Kachur; Salim Abdulla; Peter Bloland; Anne Mills
Journal:  Health Policy Plan       Date:  2007-10-04       Impact factor: 3.344

9.  Combating malaria. Malaria treatment: ACT two.

Authors:  Martin Enserink
Journal:  Science       Date:  2007-10-26       Impact factor: 47.728

10.  Fever treatment and household wealth: the challenge posed for rolling out combination therapy for malaria.

Authors:  J D Njau; C Goodman; S P Kachur; N Palmer; R A Khatib; S Abdulla; A Mills; P Bloland
Journal:  Trop Med Int Health       Date:  2006-03       Impact factor: 2.622

View more
  12 in total

Review 1.  Retail sector distribution chains for malaria treatment in the developing world: a review of the literature.

Authors:  Edith Patouillard; Kara G Hanson; Catherine A Goodman
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

2.  Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi.

Authors:  John H Amuasi; Graciela Diap; Samuel Blay-Nguah; Isaac Boakye; Patrick E Karikari; Baza Dismas; Jeanne Karenzo; Lievin Nsabiyumva; Karly S Louie; Jean-René Kiechel
Journal:  Malar J       Date:  2011-02-10       Impact factor: 2.979

3.  Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.

Authors:  Sandra Alba; Manuel W Hetzel; Catherine Goodman; Angel Dillip; Jafari Liana; Hassan Mshinda; Christian Lengeler
Journal:  Malar J       Date:  2010-06-15       Impact factor: 2.979

4.  Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.

Authors:  Kathryn A O'Connell; Hellen Gatakaa; Stephen Poyer; Julius Njogu; Illah Evance; Erik Munroe; Tsione Solomon; Catherine Goodman; Kara Hanson; Cyprien Zinsou; Louis Akulayi; Jacky Raharinjatovo; Ekundayo Arogundade; Peter Buyungo; Felton Mpasela; Chérifatou Bello Adjibabi; Jean Angbalu Agbango; Benjamin Fanomezana Ramarosandratana; Babajide Coker; Denis Rubahika; Busiku Hamainza; Steven Chapman; Tanya Shewchuk; Desmond Chavasse
Journal:  Malar J       Date:  2011-10-31       Impact factor: 2.979

5.  Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia.

Authors:  Edith Patouillard; Kara Hanson; Immo Kleinschmidt; Benjamin Palafox; Sarah Tougher; Sochea Pok; Kate O'Connell; Catherine Goodman
Journal:  Malar J       Date:  2015-05-30       Impact factor: 2.979

6.  Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.

Authors:  Carren A Watsierah; Collins Ouma
Journal:  Malar J       Date:  2014-07-28       Impact factor: 2.979

7.  Optimal price subsidies for appropriate malaria testing and treatment behaviour.

Authors:  Kristian Schultz Hansen; Tine Hjernø Lesner; Lars Peter Østerdal
Journal:  Malar J       Date:  2016-11-04       Impact factor: 2.979

8.  Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.

Authors:  Kathleen Maloney; Abigail Ward; Bonnie Krenz; Nora Petty; Lindsay Bryson; Caitlin Dolkart; Theodoor Visser; Arnaud Le Menach; Valerie K Scott; Justin M Cohen; Esther Mtumbuka; Sigsbert Mkude
Journal:  Malar J       Date:  2017-01-03       Impact factor: 2.979

9.  Methods for implementing a medicine outlet survey: lessons from the anti-malarial market.

Authors:  Kathryn A O'Connell; Stephen Poyer; Tsione Solomon; Erik Munroe; Edith Patouillard; Julius Njogu; Illah Evance; Kara Hanson; Tanya Shewchuk; Catherine Goodman
Journal:  Malar J       Date:  2013-02-05       Impact factor: 2.979

10.  Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys.

Authors:  Edith Patouillard; Immo Kleinschmidt; Kara Hanson; Sochea Pok; Benjamin Palafox; Sarah Tougher; Kate O'Connell; Catherine Goodman
Journal:  Malar J       Date:  2013-09-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.